LEVOCETRIZINE AND DESLORATADINE: COMPARATIVE EFFICACY IN PATIENTS WITH ALLERGIC RHINITIS

被引:0
|
作者
Khan, Shimal [1 ]
Khan, Muhammad Ismail
Khan, Asmatullah
Abrar, Amjad
机构
[1] Gomal Med Coll, Dept Pharmacol, Dera Ismail Khan, Pakistan
来源
GOMAL JOURNAL OF MEDICAL SCIENCES | 2012年 / 10卷 / 01期
关键词
Allergic rhinitis; Levocetrizine; Desloratadine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Antihistamines are the most commonly prescribed class of medication for allergic rhinitis. The objective of this study was to compare efficacy of levocetrizine and desloratadine in once daily dosage in patients suffering from allergic rhinitis. Methods: This study was carried out from 1st January 2011 to 31st December 2011, in Department of ENT and Pharmacology, Gomal Medical College D. I. Khan. Patients of > 12 years age with symptomatic allergic rhinitis attending ENT OPD were included. They were divided in two groups. Group A was given levocetrizine 5 mg once daily and Group B desloratadine 5 mg once daily. Data was collected at first visit prior to medication, second visit 2 weeks and third at 4 weeks. Total-4 nasal symptoms score (rhinorrhoea, sneezing, nasal itching, and nasal obstruction) were compared. Results: A Total 140 patients were included; 42 males and 28 females in group A while 52 males and 18 females in group B. Mean age in group A was 27.4 +/- 9.3 while in group B 27.5 +/- 8.9 years. Total-4 nasal symptoms score was 13-14 in 76% patients at visit 1 in levocetrizine group that improved to 6-7 in 25% and 4-5 in 70% patients at visit 2 and 3 respectively. Patients receiving desloratadine had 13-14 in 58% at visit 1 with an improvement to 4-5 in 21% and 65% at visits 2 and 3 respectively. Conclusion: There is no difference between levocetrizine and desloratadine in relieving individual symptom score in symptomatic allergic rhinitis.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 50 条
  • [41] Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis
    Ciebiada, Maciej
    Gorska-Ciebiada, Malgorzata
    Barylski, Marcin
    Kmiecik, Tomasz
    Gorski, Pawel
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2011, 25 (01) : E1 - E6
  • [42] Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study
    Yonekura, Syuji
    Okamoto, Yoshitaka
    Sakurai, Daiju
    Iinuma, Tomohisa
    Sakurai, Toshioki
    Yoneda, Riyo
    Kurita, Junya
    Hanazawa, Toyoyuki
    Kawasaki, Yohei
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 180 (04) : 274 - 283
  • [43] COMPARATIVE EFFICACY AND SAFETY OF AZATADINE AND PHENIRAMINE IN ALLERGIC RHINITIS
    REGE, SR
    SHARMA, SD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (03): : 378 - 382
  • [44] The effects of mometasone furoate and desloratadine in obstructive sleep apnea syndrome patients with allergic rhinitis
    Acar, Mustafa
    Cingi, Cemal
    Sakallioglu, Oner
    San, Turhan
    Yimenicioglu, Mehmet Fatih
    Bal, Cengiz
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (04) : E113 - E116
  • [45] Desloratadine for the treatment of cypress pollen-induced allergic rhinitis
    Demoly, Pascal
    Dreyfus, Isabelle
    Dhivert-Donnadieu, Henriette
    Mesbah, Kamal
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (03) : 260 - 266
  • [46] 24-Hour efficacy of once-daily desloratadine therapy in patients withseasonal allergic rhinitis [ISRCTN32042139]
    Salmun L.M.
    Lorber R.
    BMC Family Practice, 3 (1) : 1 - 6
  • [47] Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: A pilot study
    Ciprandi, G
    Cirillo, I
    Vizzaccaro, A
    Civardi, E
    Barberi, S
    Allen, M
    Marseglia, GL
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (13-14) : 1800 - 1808
  • [48] Comparative effects of desloratadine versus montelukast on asthma symptoms and use of β2-agonists in patients with seasonal allergic rhinitis and asthma
    Baena-Cagnani, CE
    Berger, WE
    DuBuske, LM
    Gurné, SE
    Stryszak, P
    Lorber, R
    Danzig, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2003, 130 (04) : 307 - 313
  • [49] Intermittent and persistent allergic rhinitis: new AMM specifications for Desloratadine
    Neel, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2007, 134 (01): : 111 - 112
  • [50] Safety and Efficacy of Desloratadine in Subjects with Seasonal Allergic Rhinitis or Chronic UrticariaResults of Four Postmarketing Surveillance Studies
    Claus Bachert
    Marcus Maurer
    Clinical Drug Investigation, 2010, 30 : 109 - 122